A mother faked cancer to swindle her partner out of $32,000 for 'treatment' when she was actually spending the money on ...

A father-of-three who had cancerous breast tissue removed said he feels "complete" again after getting a realistic "3D" ...

ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

IBC is a rare, aggressive breast cancer with higher rates in younger women and those of African descent, requiring a ...

Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly ...

Pfizer and Arvinas' experimental breast cancer treatment failed to delay the progression of the disease in a broader group of ...

Topline results from the Phase III VERITAC-2 trial found that vepdegestrant provided a statistically significant and clinically meaningful improvement in progression-free survival in patients with ER+ ...

An experimental breast cancer treatment co-developed by Pfizer and Arvinas significantly improved the time some patients ...

Breast cancer is the second leading cause of cancer deaths in women in the U.S., killing more than 42,000 last year ...

The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ ...

About a quarter of Iowans would no longer pay co-pays and deductibles for supplemental and diagnostic breast exams under ...

A breast cancer diagnosis affects every facet of a woman’s life. While women and their families must prioritize treatment, a ...